The Tissue Implant Response Surrounding Subcutaneous TCP, HA, And ALCAP Bioceramics.

The objective of this investigation was to quantify and further elucidate the tissue-implant response in the fibrous tissue surrounding tricalcium phosphate (TCP), hydroxyapatite (HA), and aluminum calcium phosphate (ALCAP) implants when implanted subcutaneously. Sixteen animals in four experimental groups (n = 4/group) were implanted with one implant each: Group I (control, TCP), Group II (HA), and Group III (ALCAP). At 90 days post-implantation, the fibrous tissue surrounding the implants was harvested. Sections of stained fibrous tissue were evaluated for the presence of macrophages, fibrocytes, neutrophils, vascularity and thickness for all three groups using semi-automated quantitative methods. The analysis indicated Group III demonstrated a significantly higher number of neutrophils but fewer macrophages and blood vessels per high power field and had a substantially thinner fibrous tissue capsule thickness compared to Groups I and II (alpha=0.05). Group II elicited a greater response of fibroblasts compared to Groups I and III suggesting HA may provide a slightly higher degree of stability to the implant. In total, these findings suggest both TCP and HA behave similarly in vivo when compared to ALCAP and may be better choices for subcutaneous soft-tissue application compared to ALCAP.

Neovascularization And Macrophage Behavior Under The Influence Of Androgens In The Tissue-Implant Response.

Macrophages and blood vessels are critical components in the biocompatibility and functionality of implantable ceramic materials used in drug delivery applications. The purpose of this study was to examine the correlation of macrophage and neovascularization by further defining their presence, relationship, and correlation in the fibrous tissue capsule of calcium phosphate (TCP) ceramic drug delivery systems. Sixteen animals in four experimental groups were implanted with one TCP bioceramic each. Group I animals were implanted with a TCP ceramic not containing a biologic (control group). Group II animals received the testosterone loaded TCP ceramic. Group III animals were implanted with the dihydrotestosterone loaded ceramic. Group IV animals received the androstenedione ceramic. At 90 days post-implantation, the animals were euthanized. Implants and fibrous tissue capsules were collected. Determination of macrophage populations and neovascularity was conducted microscopically following H&E staining and aided by ImagePro digital analysis software. Androgens have varying effects on vascularity and macrophage populations. Overall, macrophage counts were highly and significantly correlated with vascularity (p<0.05), particularly in Groups II, III, and IV. Correlations for Group I was not statistically significant. These findings suggest that presence of macrophages is be directly related to neovascularity, especially in the presence of exogenous androgens.

Morphometric evaluation of tissue-implant reaction associated with ALCAP and TCP bioceramics in vivo.

The purpose of this investigation was to correlate the thickness of the fibrous capsule and the various histological components surrounding aluminum-calcium phosphate (ALCAP) and tricalcium phosphate (TCP) bioceramics at the subcutaneous (sc) and intraperitoneal (ip) implantation sites. The rational of conducting this investigation is to further elucidate the mechanisms of tissue-implant interaction. Thirteen Sprague-Dawley adult male albino rats were randomly divided into three groups. Animals in groups I and II (n = 5/group) were implanted at both ip and sc implantation sites with either ALCAP or TCP ceramics, respectively. Animals in group III (n = 3) were not implanted and served as the intact control for the comparative purposes. At 90 days postimplantation, the animals in all groups were euthanized (Ketamine/Zylazane) and the fibrous tissue surrounding the ceramic devices was retrieved. After routine histological processing, sections (5 microm) of tissue was stained with hematoxylin and eosin (H&E) and evaluated using light microscopy. With the exception ofneutrophils, at both implantation sites, the fibrous tissues surrounding the TCP bioceramics demonstrated greater capsular thickness, more vascularity, and more macrophages, fibroblasts, and collagen than those surrounding the ALCAP ceramic. Data obtained from this investigation provided further insights into the differences in the tissue-implant responses of calcium-phosphate-based ceramics and the cellular composition of the fibrous tissue reaction found at sc and ip implantation sites.

Dosimetry of intravenously administered oxygen-15 labelled water in man: a model based on experimental human data from 21 subjects.

Models based on uniform distribution of tracer in total body water underestimate the absorbed dose from H2(15)O because of the short half-life (2.04 min) of 15O, which leads to non-uniform distribution of absorbed dose and also complicates the direct measurement of organ retention curves. However, organ absorbed doses can be predicted by the present kinetic model based on the convolution technique. The measured time course of arterial H2(15)O concentration following intravenous administration represents the input function to organs. The impulse response of a given organ is its transit time function determined by blood flow and the partition of water between tissue and blood. Values of these two parameters were taken from the literature. Integrals of the arterial input function and organ transit time functions were used to derive integrals of organ retention functions (organ residence times). The latter were used with absorbed dose calculation software (MIRDOSE-2) to obtain estimates for 24 organs. From the mean values of organ absorbed doses, the effective dose equivalent (EDE) and effective dose (ED) were calculated. From measurements on 21 subjects, the average value for both EDE and ED was calculated to be 1.2 microSv.MBq-1 compared with a value of about 0.5 microSv.MBq-1 predicted by uniform water distribution models. Based on the human data, a method of approximating H2(15)O absorbed dose values from body surface area is described.

A partial decay scheme study of 82Rb and consequences for radiation dose measurements.

Measurements of the relative emission rates of the 776 keV gamma ray, the positrons and the K x-rays in the decay of 82Rb have been repeated. This has led to the finding that the gamma ray to positron ratio is 0.1578 +/- 0.0019 and that the 776 keV gamma-ray probability per decay is (15.12 +/- 0.18)%.

Radioassay problems associated with the clinical use of a 82Rb radionuclide generator.

The short-lived positron emitting radionuclide 82Rb (t1/2 1.27 min) is conveniently available from a 82Sr/82Rb generator system. The parent nuclide (t1/2 25.5d) produced from the spallation of molybdenum, has associated with it varying quantities of other long-lived strontium radionuclides, namely 85Sr, 89Sr and 90Sr. It is important therefore in the clinical use of such material that the levels of strontium radionuclides being administered to patients is carefully assayed and controlled. The problems associated with these measurements are discussed with special reference to the radiation dose received by the patient and the problems in resolving overlapping peaks with different FWHMs.